Structures by: Capet F.
Total: 54
6-Bromo-2-(4-chlorophenyl)-3-[(1-octyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C23H26BrClN6
IUCrData (2019) 4, 1 x190053
a=16.252(3)Å b=5.3787(9)Å c=27.109(4)Å
α=90° β=90.551(12)° γ=90°
1,1'-(Hexane-1,6-diyl)bis(indoline-2,3-dione)
C22H20N2O4
IUCrData (2016) 1, 4 x160542
a=15.1498(3)Å b=7.4949(2)Å c=16.4795(3)Å
α=90° β=90° γ=90°
1-[(2<i>E</i>)-3-Phenylprop-2-en-1-yl]-1<i>H</i>-indole-2,3-dione
C17H13NO2
IUCrData (2016) 1, 4 x160633
a=8.2585(2)Å b=7.26770(10)Å c=44.4667(8)Å
α=90° β=90° γ=90°
1-(3-Bromopropyl)indoline-2,3-dione
C11H10BrNO2
IUCrData (2016) 1, 4 x160593
a=7.7113(2)Å b=8.1375(2)Å c=17.8089(4)Å
α=90° β=93.8300(13)° γ=90°
1-Propyl-1<i>H</i>-indole-2,3-dione
C11H11NO2
IUCrData (2016) 1, 4 x160609
a=4.4666(2)Å b=12.9169(6)Å c=16.3857(8)Å
α=90° β=90° γ=90°
5-Bromo-1-octylindoline-2,3-dione
C16H20BrNO2
IUCrData (2016) 1, 3 x160371
a=4.5284(2)Å b=13.2044(6)Å c=25.9133(11)Å
α=96.663(3)° β=90.728(3)° γ=95.393(3)°
5-Bromo-1-nonylindoline-2,3-dione
C17H22BrNO2
IUCrData (2016) 1, 5 x160791
a=4.8428(2)Å b=31.7181(14)Å c=10.7171(5)Å
α=90° β=101.206(2)° γ=90°
1-Allyl-5-chloroindoline-2,3-dione
C11H8ClNO2
IUCrData (2016) 1, 6 x160862
a=31.2222(6)Å b=7.9107(2)Å c=8.3373(2)Å
α=90° β=90° γ=90°
5-Bromo-1-(6-bromohexyl)indoline-2,3-dione
C14H15Br2NO2
IUCrData (2016) 1, 6 x160883
a=4.6344(2)Å b=12.6284(6)Å c=25.3537(12)Å
α=90° β=90° γ=90°
1-Benzyl-5-chloroindoline-2,3-dione
C15H10ClNO2
IUCrData (2016) 1, 6 x160854
a=4.4576(2)Å b=27.6646(11)Å c=20.9530(8)Å
α=90° β=93.870(2)° γ=90°
5-Bromo-1-methylindoline-2,3-dione
C9H6BrNO2
IUCrData (2016) 1, 5 x160792
a=4.06340(10)Å b=11.9235(3)Å c=18.0978(5)Å
α=90° β=96.170(2)° γ=90°
5-Chloro-1-methylindoline-2,3-dione
C9H6ClNO2
IUCrData (2016) 1, 6 x160913
a=3.9766(4)Å b=11.9503(13)Å c=17.947(2)Å
α=90° β=96.163(3)° γ=90°
C16H18N2O2S
C16H18N2O2S
New J. Chem. (2016) 40, 11 9034
a=6.4138(6)Å b=7.6858(7)Å c=15.2182(14)Å
α=90° β=99.722(3)° γ=90°
1-(12-Bromododecyl)-5-chloroindoline-2,3-dione
C20H27BrClNO2
IUCrData (2016) 1, 6 x160971
a=8.0353(4)Å b=8.3496(5)Å c=17.1096(11)Å
α=84.491(3)° β=78.086(3)° γ=65.126(2)°
C4H12Al1Li1
C4H12Al1Li1
The Journal of Physical Chemistry C (2013) 117, 35 18091
a=6.2978(2)Å b=11.6066(3)Å c=9.6537(3)Å
α=90.00° β=95.7480(10)° γ=90.00°
Carbonyl(trihydroborato)(hydruro)[bis(2-diisopropylphosphinoethyl)amido] ruthenium(II)
C17H40BNOP2Ru
Green Chem. (2017)
a=14.1736(5)Å b=15.6168(7)Å c=20.0291(8)Å
α=90° β=90° γ=90°
C16H44AlClN2OSi4
C16H44AlClN2OSi4
Dalton transactions (Cambridge, England : 2003) (2019) 48, 16 5243-5252
a=8.3419(4)Å b=11.3931(5)Å c=15.5621(7)Å
α=104.962(2)° β=93.099(2)° γ=109.088(2)°
Caffeine
C8H10N4O2
Acta Crystallographica Section B (2005) 61, 3 329-334
a=14.9372(5)Å b=14.9372(5)Å c=6.8980(2)Å
α=90.00000° β=90.00000° γ=120.00000°
4-Allyl-6-bromo-2-(4-chlorophenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C15H11BrClN3
Acta Crystallographica Section E (2019) 75, 1 43-48
a=7.6218(5)Å b=8.5238(5)Å c=11.1093(7)Å
α=95.739(3)° β=98.880(3)° γ=94.979(3)°
5,5-Diphenyl-1,3-bis(prop-2-yn-1-yl)imidazolidine-2,4-dione
C21H16N2O2
Acta Crystallographica Section E (2019) 75, 7 951-956
a=10.144(3)Å b=7.952(2)Å c=10.928(3)Å
α=90° β=97.104(12)° γ=90°
5-Bromo-1-{2-[2-(2-chloroethoxy)ethoxy]ethyl}indoline-2,3-dione
C14H15BrClNO4
Acta Crystallographica Section E (2019) 75, 9 1372-1378
a=12.4682(4)Å b=14.6397(5)Å c=8.3524(3)Å
α=90° β=91.392(2)° γ=90°
Tris[4-(dimethylamino)pyridinium] tris(oxalato-κ^2^<i>O</i>,<i>O</i>)chromate(III) tetrahydrate
3(C7H11N2),C6CrO123,4(H2O)
Acta Crystallographica Section E (2015) 71, 11 1408-1410
a=19.1141(5)Å b=16.7537(4)Å c=11.0053(2)Å
α=90° β=98.8030(10)° γ=90°
5-Bromo-1-ethylindoline-2,3-dione
C10H8BrNO2
Acta Crystallographica Section E (2015) 71, 12 o1024-o1025
a=9.5198(3)Å b=10.0655(3)Å c=11.2341(3)Å
α=70.9288(16)° β=75.4109(16)° γ=85.2199(16)°
4-(Dimethylamino)pyridinium <i>cis</i>-diaquabis(oxalato-κ^2^<i>O</i>,<i>O</i>)ferrate(III) hemihydrate
C7H11N2,C4H4FeO10,0.5(H2O)
Acta Crystallographica Section E (2015) 71, 8 934-936
a=14.7960(7)Å b=10.4422(4)Å c=21.7751(10)Å
α=90° β=108.352(3)° γ=90°
6-Bromo-1-(1,2-propadienyl)-3-(2-propynyl)-1<i>H</i>- imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C12H8BrN3O
Acta Crystallographica Section E (2010) 66, 4 o755
a=9.6369(4)Å b=9.3086(4)Å c=13.5481(5)Å
α=90.00° β=99.123(2)° γ=90.00°
6-Bromo-1,3-di-2-propynyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin- 2(3<i>H</i>)-one
C12H8BrN3O
Acta Crystallographica Section E (2010) 66, 4 o756
a=9.0725(3)Å b=18.6212(5)Å c=7.0684(2)Å
α=90.00° β=102.9950(10)° γ=90.00°
1,3-Dibenzyl-6-bromo-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C20H16BrN3O
Acta Crystallographica Section E (2010) 66, 4 o754
a=9.16270(10)Å b=25.5071(3)Å c=8.06290(10)Å
α=90.00° β=115.5710(10)° γ=90.00°
4-Benzyl-6-bromo-2-phenyl-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C19H14BrN3
Acta Crystallographica Section E (2010) 66, 4 o946
a=8.6613(6)Å b=19.7631(13)Å c=9.3683(6)Å
α=90.00° β=99.647(3)° γ=90.00°
6-Bromo-3-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C7H6BrN3O
Acta Crystallographica Section E (2010) 66, 5 o1080
a=4.41510(10)Å b=9.6004(2)Å c=10.5330(3)Å
α=116.2480(10)° β=93.074(2)° γ=91.6870(10)°
8-Bromo-3,4-dihydro-2<i>H</i>1,3-thiazino[2,3:2',1']imidazo[5',4'- <i>b</i>]pyridine
C9H8BrN3S
Acta Crystallographica Section E (2010) 66, 5 o1079
a=20.2738(3)Å b=13.2786(2)Å c=7.31690(10)Å
α=90.00° β=102.1930(10)° γ=90.00°
1,3-Dibenzyl-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione
C29H20N2O3
Acta Crystallographica Section E (2011) 67, 5 o1253-o1254
a=8.1389(3)Å b=12.8748(4)Å c=21.5528(8)Å
α=90.00° β=90.00° γ=90.00°
Diethyl 2,6,11-trioxo-2,3-dihydro-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-1,3-diacetate
C23H20N2O7
Acta Crystallographica Section E (2011) 67, 8 o2081
a=17.4620(10)Å b=13.0646(9)Å c=9.1411(6)Å
α=90.00° β=103.915(3)° γ=90.00°
1,3-Bis[3-(1,3-dioxoisoindolin-2-yl)propyl]-1<i>H</i>- anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione
C37H26N4O7
Acta Crystallographica Section E (2011) 67, 8 o2137
a=8.4278(2)Å b=13.1258(3)Å c=13.7966(3)Å
α=94.3590(10)° β=92.4720(10)° γ=105.3510(10)°
<i>trans</i>-Diaquabis[2,5-bis(pyridin-2-yl)-1,3,4-thiadiazole]nickel(II) bis(tetrafluoridoborate)
C24H20N8NiO2S22,2(BF4)
Acta Crystallographica Section E (2011) 67, 8 m1052-m1053
a=10.8164(15)Å b=11.0126(13)Å c=13.2333(16)Å
α=90.00° β=101.455(6)° γ=90.00°
1-Allyl-3-benzyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C17H16N2O
Acta Crystallographica Section E (2013) 69, 9 o1477-o1478
a=9.0667(2)Å b=9.3922(2)Å c=9.6486(2)Å
α=94.2180(10)° β=113.5430(10)° γ=106.2650(10)°
3-Allyl-1-{[3-(4-nitrophenyl)-4,5-dihydro-1,3-oxazol-5-yl]methyl}-1<i>H</i>- anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione
C28H20N4O6
Acta Crystallographica Section E (2011) 67, 6 o1363-o1364
a=10.0780(3)Å b=22.7094(6)Å c=11.2729(3)Å
α=90.00° β=113.8090(10)° γ=90.00°
<i>trans</i>-Diaquabis[2,5-bis(pyridin-2-yl)-1,3,4-thiadiazole]cobalt(II) bis(tetrafluoridoborate)
C24H20CoN8O2S22,2(BF4)
Acta Crystallographica Section E (2011) 67, 7 m834-m835
a=10.8319(2)Å b=11.0623(2)Å c=13.2120(3)Å
α=90.00° β=101.1140(10)° γ=90.00°
6-Bromoimidazo[1,2-<i>a</i>]pyridin-8-amine
C7H6BrN3
Acta Crystallographica Section E (2011) 67, 11 o2838
a=15.1378(5)Å b=21.2006(8)Å c=6.9744(3)Å
α=90.00° β=92.6106(7)° γ=90.00°
3-Benzyl-6-bromo-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C13H10BrN3O
Acta Crystallographica Section E (2013) 69, 6 o962
a=4.2399(2)Å b=10.4463(4)Å c=14.5144(6)Å
α=107.611(2)° β=90.628(3)° γ=99.784(3)°
1,3-Bis(prop-2-yn-1-yl)-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione
C21H12N2O3
Acta Crystallographica Section E (2013) 69, 6 o944
a=16.6972(5)Å b=4.56020(10)Å c=21.2500(5)Å
α=90.00° β=96.352(2)° γ=90.00°
1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-dihydroisoxazol-5-yl]methyl}-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione
C27H20N4O4
Acta Crystallographica Section E (2013) 69, 6 o945-o946
a=8.0930(2)Å b=12.1191(3)Å c=12.2743(2)Å
α=87.1090(10)° β=73.6120(10)° γ=72.2830(10)°
6-Bromo-1,3-bis[(1,3-dioxolan-2-yl)methyl]-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C14H16BrN3O5
Acta Crystallographica Section E (2013) 69, 7 o1029-o1030
a=5.11440(10)Å b=17.8029(4)Å c=16.5365(5)Å
α=90.00° β=97.009(2)° γ=90.00°
3-Benzyl-1-{[3-(4-chlorophenyl)isoxazol-5-yl]methyl}-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C24H18ClN3O2
Acta Crystallographica Section E (2013) 69, 9 o1451
a=8.5427(2)Å b=9.8290(2)Å c=13.2658(3)Å
α=81.1330(10)° β=78.7630(10)° γ=64.3430(10)°
C32H35ClNiP2
C32H35ClNiP2
ACS Catalysis (2017) 7, 10 6915
a=10.3622(4)Å b=11.0841(3)Å c=13.1883(5)Å
α=100.947(2)° β=102.623(2)° γ=105.014(2)°
C36H35ClNiP2,C7H8
C36H35ClNiP2,C7H8
ACS Catalysis (2017) 7, 10 6915
a=12.3832(5)Å b=17.1052(6)Å c=17.3844(7)Å
α=90° β=106.111(2)° γ=90°
C25H44MnNO3P2
C25H44MnNO3P2
ACS Catalysis (2017) 7, 3 2022
a=30.3732(14)Å b=11.6836(6)Å c=7.6516(4)Å
α=90° β=90° γ=90°
C18H38MnNO2P2
C18H38MnNO2P2
ACS Catalysis (2017) 7, 3 2022
a=10.6335(8)Å b=14.5777(11)Å c=13.8441(10)Å
α=90° β=97.449(4)° γ=90°
C18H41BMnNO2P2
C18H41BMnNO2P2
ACS Catalysis (2017) 7, 3 2022
a=17.2037(18)Å b=14.6522(17)Å c=19.066(2)Å
α=90° β=90° γ=90°
C19H41NO3P2Ru
C19H41NO3P2Ru
ACS Catalysis (2018) 8, 5 4719
a=14.1700(5)Å b=15.3918(6)Å c=21.7410(8)Å
α=90° β=90° γ=90°
C19H43NO2P2Ru,C2H6O
C19H43NO2P2Ru,C2H6O
ACS Catalysis (2018) 8, 5 4719
a=13.2573(9)Å b=13.3386(8)Å c=15.3535(10)Å
α=90° β=92.948(4)° γ=90°
3(C17H39NO2P2Ru),4(H2O)
3(C17H39NO2P2Ru),4(H2O)
ACS Catalysis (2018) 8, 5 4719
a=15.1793(5)Å b=16.5074(8)Å c=16.6640(6)Å
α=88.609(2)° β=71.881(2)° γ=62.8250(10)°
Bi23.346Cu4.654Li4O72P12
Bi23.346Cu4.654Li4O72P12
Inorganic Chemistry (2012) 51, 9557-9562
a=11.4096(4)Å b=5.4333(2)Å c=25.1315(9)Å
α=90° β=90° γ=90°
Bi39.615Cu5.671Li6.72O120P20
Bi39.615Cu5.671Li6.72O120P20
Inorganic Chemistry (2012) 51, 9557-9562
a=11.5048(10)Å b=5.4565(6)Å c=41.656(3)Å
α=90° β=90° γ=90°
1,3-Bis(naphthalen-2-ylmethyl)-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole- 2,6,11(3<i>H</i>)-trione
C37H24N2O3
Acta Crystallographica Section E (2011) 67, 8 o2138
a=8.09010(10)Å b=12.8226(2)Å c=26.1472(4)Å
α=90.00° β=90.00° γ=90.00°